Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
The patient (b)(6) physician later reported that they are not sure what is causing the pain, but suspect it to be related to the presence of the device and not necessarily stimulation.The referral for a battery replacement was intervention to preclude serious injury.A chest x-ray was performed for the chest pain, and per physician, there were no anomalies identified related to the vns.No other relevant information has been received to date.No known relevant surgical intervention has occurred to date.
|